PA
KFRC icon

PharVision Advisers’s Kforce KFRC Stock Holding History

PharVision Advisers’s Portfolio KFRC Stock Details KFRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6,590
Closed -$204K – 390
2025
Q4 		$204K Buy
+6,590
New +$194K 0.1% 543

Other funds holding KFRC

Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
NSCM
New South Capital Management Memphis, Tennessee $2.28B AUM 47.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
DRZID
DePrince Race & Zollo Inc (DRZ) Winter Park, Florida $5.96B AUM 38.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

PharVision Advisers's KFRC Position: Q1 2026 in Review

PharVision Advisers sold out of Kforce (KFRC) in Q1 2026, closing a stake of 6,590 shares — an estimated $204K sold.

PharVision Advisers first reported a position in KFRC in Q4 2025 and held it in 1 quarter. The position peaked at $204K in Q4 2025. 204 funds tracked by Wall St. Rank hold KFRC as of Q1 2026.

  • PharVision Advisers reported no remaining Kforce position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 6,590 Kforce shares in Q1 2026, an estimated $204K.
  • PharVision Advisers first reported a position in Kforce in Q4 2025 and held it in 1 quarter.
  • PharVision Advisers's Kforce position peaked at $204K in Q4 2025.
  • 204 funds tracked by Wall St. Rank held Kforce as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.